A detailed history of Flagship Harbor Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Flagship Harbor Advisors, LLC holds 13,083 shares of NVO stock, worth $1.38 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
13,083
Previous 12,451 5.08%
Holding current value
$1.38 Million
Previous $1.6 Million 2.57%
% of portfolio
0.09%
Previous 0.1%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$119.07 - $145.42 $75,252 - $91,905
632 Added 5.08%
13,083 $1.56 Million
Q1 2024

Apr 16, 2024

BUY
$102.11 - $135.92 $59,325 - $78,969
581 Added 4.89%
12,451 $1.6 Million
Q4 2023

Jan 10, 2024

BUY
$87.78 - $105.45 $52,053 - $62,531
593 Added 5.26%
11,870 $1.23 Million
Q3 2023

Oct 17, 2023

BUY
$90.94 - $199.54 $582,743 - $1.28 Million
6,408 Added 131.61%
11,277 $1.03 Million
Q2 2023

Jul 11, 2023

BUY
$155.98 - $172.65 $202,929 - $224,617
1,301 Added 36.46%
4,869 $787,000
Q1 2023

Apr 12, 2023

BUY
$132.34 - $159.14 $29,511 - $35,488
223 Added 6.67%
3,568 $567,000
Q4 2022

Jan 13, 2023

SELL
$102.55 - $135.33 $21,227 - $28,013
-207 Reduced 5.83%
3,345 $0
Q3 2022

Oct 13, 2022

BUY
$95.28 - $116.93 $6,097 - $7,483
64 Added 1.83%
3,552 $354,000
Q2 2022

Jul 13, 2022

BUY
$103.24 - $121.81 $6,091 - $7,186
59 Added 1.72%
3,488 $389,000
Q1 2022

Apr 13, 2022

SELL
$93.1 - $112.54 $9,310 - $11,254
-100 Reduced 2.83%
3,429 $381,000
Q4 2021

Feb 10, 2022

BUY
$95.88 - $117.08 $98,085 - $119,772
1,023 Added 40.82%
3,529 $395,000
Q2 2021

Jul 26, 2021

BUY
$67.66 - $84.76 $169,555 - $212,408
2,506 New
2,506 $210,000
Q4 2020

Feb 08, 2021

SELL
$63.89 - $73.8 $132,571 - $153,135
-2,075 Closed
0 $0
Q3 2020

Oct 13, 2020

SELL
$63.69 - $70.22 $8,725 - $9,620
-137 Reduced 6.19%
2,075 $144,000
Q2 2020

Jul 31, 2020

BUY
$58.54 - $67.94 $83,068 - $96,406
1,419 Added 178.94%
2,212 $144,000
Q1 2020

May 12, 2020

BUY
$49.46 - $64.78 $3,808 - $4,988
77 Added 10.75%
793 $48,000
Q4 2019

Feb 14, 2020

BUY
$49.86 - $58.26 $49 - $58
1 Added 0.14%
716 $41,000
Q3 2019

Oct 22, 2019

BUY
$47.54 - $53.43 $190 - $213
4 Added 0.56%
715 $37,000
Q2 2019

Jul 22, 2019

SELL
$46.79 - $52.47 $5,801 - $6,506
-124 Reduced 14.85%
711 $36,000
Q1 2019

Apr 15, 2019

SELL
$46.36 - $52.63 $5,795 - $6,578
-125 Reduced 13.02%
835 $43,000
Q4 2018

Jan 28, 2019

SELL
$41.54 - $47.25 $22,722 - $25,845
-547 Reduced 36.3%
960 $44,000
Q3 2018

Nov 05, 2018

BUY
$46.76 - $51.24 $327 - $358
7 Added 0.47%
1,507 $70,000
Q2 2018

Aug 14, 2018

BUY
$44.29 - $50.42 $66,435 - $75,630
1,500 New
1,500 $69,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Flagship Harbor Advisors, LLC Portfolio

Follow Flagship Harbor Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.